Emergent BioSolutions Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 156.1M | 148.7M | 231.1M | 140.9M | 222.2M | 194.7M | 293.8M | 254.7M |
| Cost of Goods Sold | 88.5M | 102.1M | 102.0M | 83.4M | 105.7M | 58.2M | 129.6M | 320.2M |
| Gross Profit | 67.6M | 46.6M | 129.1M | 57.5M | 116.5M | 136.5M | 164.2M | -65.5M |
| R&D Expenses | 10.5M | 12.1M | 13.5M | 13.0M | 15.2M | 9.1M | 13.8M | 32.7M |
| Operating Expenses | 57.1M | 63.2M | 52.3M | 57.0M | 67.9M | 146.0M | 99.7M | 138.0M |
| Operating Income | 10.5M | -16.6M | 76.8M | 500K | 48.6M | -9.5M | 64.5M | -203.5M |
| Other Income / Gains | 2.9M | -34.1M | -19.2M | -17.3M | 44.1M | -18.1M | 77.9M | -66.3M |
| Net Income | 6.8M | -54.6M | 51.2M | -12.0M | 68.0M | -31.3M | 114.8M | -283.1M |
| EPS (Diluted) | 0.13 | -1.04 | 0.96 | -0.22 | 1.25 | -0.59 | 2.16 | -5.38 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.433 | 0.313 | 0.559 | 0.408 | 0.524 | 0.701 | 0.559 | -0.257 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 46.6M | 51.1M | 38.8M | 44.0M | 52.7M | 60.7M | 75.9M | 77.3M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 76.2M | 10.0M | 28.0M |
| Cost And Expenses | 145.6M | 165.3M | 154.3M | 140.4M | 173.6M | 204.2M | 229.3M | 458.2M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 11.0M | 14.7M | 15.2M | 14.7M | 14.7M | 14.8M | 8.3M | 23.6M |
| Depreciation And Amortization | 24.1M | 23.5M | 23.8M | 24.0M | 26.0M | 25.3M | 25.7M | 27.6M |
| Ebitda | 48.5M | -12.5M | 96.6M | 21.9M | 133.4M | 21.0M | 97.7M | -131.5M |
| Ebitdaratio | 0.311 | -0.084 | 0.418 | 0.155 | 0.60 | 0.108 | 0.333 | -0.516 |
| Operating Income Ratio | 0.067 | -0.112 | 0.332 | 0.004 | 0.219 | -0.049 | 0.22 | -0.799 |
| Income Before Tax | 13.4M | -50.7M | 57.6M | -16.8M | 92.7M | -27.6M | 142.4M | -269.8M |
| Income Before Tax Ratio | 0.086 | -0.341 | 0.249 | -0.119 | 0.417 | -0.142 | 0.485 | -1.059 |
| Income Tax Expense | 6.6M | 3.9M | 6.4M | -4.8M | 24.7M | 3.7M | 27.6M | 13.3M |
| Net Income Ratio | 0.044 | -0.367 | 0.222 | -0.085 | 0.306 | -0.161 | 0.391 | -1.112 |
| Epsdiluted | 0.074 | -1.04 | 0.91 | -0.22 | 1.19 | -0.59 | 2.06 | -5.38 |
| Weighted Average Shs Out | 51.9M | 52.4M | 53.2M | 54.2M | 54.4M | 54.2M | 53.1M | 52.6M |
| Weighted Average Shs Out Dil | 56.5M | 52.4M | 56.5M | 54.2M | 57.3M | 54.2M | 55.6M | 52.6M |